Contact

US- BHE project funded by FEDER

A controlled opening device of the blood-brain barrier by combined use of MRI and ultrasound  is now installed in MirCen  This equipment has been funded by FEDER.

Read more...

Gene Therapy in Parkinson's Disease

Ph Hantraye’ Conference at the Mediatheque of Fontenay aux Roses 

Read more...

Memory and epilepsy: the role of connexin 30

Memory and epilepsy: the role of connexin 30

CEA-I2BM shows that connexin 30 is a new potential therapeutic target to increase memory or reduce seizures in patients with epilepsy.

"Connexin 30 sets synaptic strength by controlling astroglial invasion synapse" in Nature Neurosciences

Click here to learn more

Parkinson's disease: a breakthrough thanks to gene therapy

Parkinson's disease: a breakthrough thanks to gene therapy

A Franco-British team (AP-HP, INSERM, UPEC, CEA / MIRCen, Oxford Biomedica, Cambridge University) conducted a Phase I-II gene therapy clinical trial in patients with an advanced form of Parkinson’s disease.

Click here to learn more